Literature DB >> 3683349

Perinatal and developmental outcome of infants exposed to methadone in-utero.

K Kaltenbach1, L P Finnegan.   

Abstract

The purpose of this research is to delineate the effects of methadone exposure in-utero. Subjects were 141 infants born to drug dependent women maintained on methadone during pregnancy and 127 non-drug exposed comparison infants matched for race, maternal age, and socioeconomic status. Methadone exposed infants had smaller birth weights than comparison infants. Differences were also found in head circumference. However, this difference was not clinically significant but rather reflects the relationship between birth weight and head circumference. No difference was found between groups in mental development. One hundred and five methadone exposed infants and 63 comparison infants were evaluated with the Bayley Scale of Mental Development at 6 months of age. Mean Bayley Mental Development scores for methadone exposed infants and comparison infants were 103 and 105 respectively. These data suggest that while methadone exposure in-utero is associated with lower birth weight and head circumference, by six months of age, these infants do not exhibit any general developmental sequelae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683349     DOI: 10.1016/0892-0362(87)90021-3

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  12 in total

Review 1.  Pregnancy and injecting drug use.

Authors:  James Bell; Lucy Harvey-Dodds
Journal:  BMJ       Date:  2008-06-07

2.  Prescription Opioids in Pregnancy and Birth Outcomes: A Review of the Literature.

Authors:  Mahsa M Yazdy; Rishi J Desai; Susan B Brogly
Journal:  J Pediatr Genet       Date:  2015-04-01

Review 3.  Clinical teratology.

Authors:  A Ornoy; J Arnon
Journal:  West J Med       Date:  1993-09

Review 4.  Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Authors:  M Kahan; N Sutton
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

Review 5.  Neonatal abstinence syndrome: treatment and pediatric outcomes.

Authors:  Beth A Logan; Mark S Brown; Marie J Hayes
Journal:  Clin Obstet Gynecol       Date:  2013-03       Impact factor: 2.190

6.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

7.  Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea.

Authors:  Anthony Liu; Tracey Björkman; Caroline Stewart; Ralph Nanan
Journal:  Int J Pediatr       Date:  2011-05-23

8.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

Review 9.  Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.

Authors:  Andrew E Weller; Richard C Crist; Benjamin C Reiner; Glenn A Doyle; Wade H Berrettini
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

10.  Opioid treatment for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.